Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT01075386
Registration number
NCT01075386
Ethics application status
Date submitted
23/02/2010
Date registered
25/02/2010
Date last updated
28/08/2019
Titles & IDs
Public title
The Effects of the Endocrine System on Endometrial Cancer
Query!
Scientific title
Expression and Function of Ghrelin and Its Receptor, Growth Hormone Secretagogue Receptor TWEAK Protein and Its Receptor Fn14 in Human Endometrial Cancer
Query!
Secondary ID [1]
0
0
Endo01
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Ghrelin
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Endometrial Cancer
0
0
Query!
Condition category
Condition code
Cancer
0
0
0
0
Query!
Womb (Uterine or endometrial cancer)
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Grade 2 - Patients with Endometrial cancer of Grade 1 differentiation
Benign - Patients without endometrial cancer
Grade 1 - Patients with Endometrial cancer of Grade 2 differentiation
Grade 3 - Patients with Endometrial cancer of Grade 3 differentiation
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Eligibility
Key inclusion criteria
- women aged 18 years or older
- having a hysterectomy for the treatment of endometrial cancer, fibroids, chronic
pelvic pain or abnormal uterine bleeding
- have provided informed consent
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/10/2009
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/12/2018
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
75
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Recruitment hospital [1]
0
0
Greenslopes Private Hospital - Greenslopes
Query!
Recruitment postcode(s) [1]
0
0
4120 - Greenslopes
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Queensland Centre for Gynaecological Cancer
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Other
Query!
Name [1]
0
0
Greenslopes Private Hospital
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Other collaborator category [2]
0
0
Other
Query!
Name [2]
0
0
The University of Queensland
Query!
Address [2]
0
0
Query!
Country [2]
0
0
Query!
Other collaborator category [3]
0
0
Other
Query!
Name [3]
0
0
Sullivan and Nicolaides Pathology
Query!
Address [3]
0
0
Query!
Country [3]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
Endometrial cancer usually begins in the endometrium, which is the tissue lining of the
uterus. Endometrial cancer is the most commonly diagnosed gynaecological malignancy in
Australia. It affects 1 in 80 Australian women and there are about 1400 new cases and 260
deaths from the disease every year. Most affected women are aged between 50 and 70 years. The
purpose of this study is to investigate the possible role of the endocrine system in the
regulation of human endometrial cancer. By looking at the laboratory results of people with
endometrial cancer and also those without endometrial cancer we hope to gain a better
understanding of how endometrial cancer develops and progresses. This may lead to the
development of new, effective therapies for endometrial cancer.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT01075386
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Chen Chen, MD PhD
Query!
Address
0
0
The University of Queensland
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT01075386
Download to PDF